E2 ModerateModerate confidencePEM not requiredCross-SectionalPeer-reviewedReviewed
Standard · 3 min
Small-Fiber Polyneuropathy Is Prevalent in Patients With Interstitial Cystitis/Bladder Pain Syndrome.
Wolff, Dylan T, Xu, Raymond, Overholt, Tyler et al. · Urogynecology (Philadelphia, Pa.) · 2022 · DOI
Quick Summary
Researchers found that about one-third of people with bladder pain syndrome (IC/BPS) have small-fiber polyneuropathy (SFPN), a condition where tiny nerves in the skin are damaged or reduced. Notably, people with SFPN were significantly more likely to also have chronic fatigue syndrome (31% vs 10.6%). This suggests these two painful conditions may share a common nerve-related mechanism.
Why It Matters
This study is important for ME/CFS patients because it reveals a potential shared pathophysiological mechanism between IC/BPS and ME/CFS—small-fiber neuropathy. Since IC/BPS frequently co-occurs with ME/CFS, understanding the role of small-fiber nerve damage may open new diagnostic and treatment avenues for both conditions. The significant association (31% SFPN+ patients have ME/CFS) suggests small-fiber pathology could be a relevant biomarker across both conditions.
Observed Findings
31% (31/100) of IC/BPS patients met criteria for SFPN based on skin biopsy
81% (81/100) of IC/BPS patients showed intraepidermal nerve fiber density below the median for age and sex
31% of SFPN-positive patients reported co-occurring chronic fatigue syndrome, compared with 10.6% of SFPN-negative patients (P=0.034)
37.9% of SFPN-positive patients reported allergies vs 60.6% of SFPN-negative patients (P=0.047)
No significant differences in bladder capacity or Hunner lesion status between SFPN+ and SFPN- subgroups
Inferred Conclusions
Small-fiber polyneuropathy is a common finding in IC/BPS patients and may represent a shared pathophysiological mechanism with ME/CFS
SFPN status is significantly associated with concurrent chronic fatigue syndrome in IC/BPS populations
SFPN status is inversely associated with allergic disease in IC/BPS, suggesting distinct immunological phenotypes
Small-fiber pathology may be a relevant biomarker for IC/BPS phenotyping and potential therapeutic targeting
Remaining Questions
What is the temporal relationship between SFPN development and IC/BPS symptom onset?
What This Study Does Not Prove
This study does not prove that small-fiber neuropathy causes IC/BPS or ME/CFS, only that the three occur together more often than expected. The cross-sectional design cannot establish temporal relationships or directionality—it is unknown whether SFPN develops before, after, or independently of symptom onset. The study also cannot determine whether SFPN drives shared symptoms or whether both result from a separate underlying mechanism.
Tags
Symptom:PainFatigue
Biomarker:Neuroimaging
Method Flag:No ControlsSmall SampleMixed CohortWeak Case Definition
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.